Andrew L. Pecora, MD
John Theurer Cancer Center (JTCC) announced in a press conference today that it has been approved by the National Cancer Institute (NCI) to become a member of the NCI-designated Georgetown Lombardi Comprehensive Cancer Center Consortium. The partnership is one of just 16 NCI-designated cancer consortia.
“Over the past 30 years, I've truly been privileged to be part of the effort that has led to the creation of the John Theurer Cancer Center and now its designation as a member of the Georgetown Lombardi Consortium,” said Andrew L. Pecora, MD, president of Physician Enterprise and chief innovations officer at Hackensack Meridian Health and professor of medicine and oncology at Georgetown University. “The NCI’s approval of the consortium represents the culmination of integrated research and collective talent and resources of two cancer centers.”
... to read the full story